Location History:
- Cambridge, GB (2009 - 2012)
- Brentford, GB (2016 - 2017)
Company Filing History:
5 out of 21 
2 out of 2,078 
2 out of 363 
Years Active: 2009-2017
Title: Inventor Jeremy Major: Innovating in Pharmaceutical Science
Introduction
Jeremy Major, based in Cambridge, GB, is a prominent inventor recognized for his contributions to pharmaceutical science. With a portfolio of seven patents, he has made significant strides in developing innovative compounds aimed at treating various immunological and inflammatory disorders.
Latest Patents
Among Jeremy's latest patents is the invention of heterocyclyl pyrimidine analogues as TYK2 inhibitors. This invention pertains to compounds defined by specific formulas aimed at providing therapeutic benefits. These compounds are instrumental in the treatment or prophylaxis of immunological, inflammatory, autoimmune, and allergic disorders, as well as other immunologically-mediated diseases. The patent also covers pharmaceutical compositions that include these compounds and their applications as medicaments.
Career Highlights
Jeremy Major has built his expertise while working at notable organizations in the pharmaceutical sector. He has contributed significantly to Cellzome Limited and Janssen Pharmaceutica NV, both of which are recognized for their innovation in drug development and research. His extensive work history allows him to leverage a wealth of knowledge in the field.
Collaborations
Throughout his career, Jeremy has collaborated with seasoned professionals, such as Richard John Harrison and Mihiro Sunose. These partnerships have likely facilitated the exchange of ideas and advancements in their respective projects, leading to more effective solutions in pharmaceutical research.
Conclusion
Jeremy Major stands out as a dedicated inventor whose work has made a tangible impact on the field of pharmaceutical sciences. His pioneering research and patented inventions are foundational for new therapies aimed at combating a range of health challenges related to immunological conditions. As he continues his innovative journey, the scientific community eagerly anticipates the outcomes of his future endeavors.